Circulation· 2013Q1

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

Sam Schulman, Ajay K. Kakkar, Samuel Z. Goldhaber, Sebastian Schellong et al.

932citations
Q1SCImago
2013year

Short summary

Dabigatran (2.3% VTE recurrence) showed similar efficacy to warfarin (2.2% VTE recurrence) in treating acute venous thromboembolism (VTE), but with significantly less overall bleeding (15.6% vs. 22.1%).

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Internal Medicine

Internal MedicineMedicine